Literature DB >> 3943200

Interlaboratory standardization of glycated hemoglobin determinations.

R R Little, J D England, H M Wiedmeyer, E M McKenzie, R Mitra, P M Erhart, J B Durham, D E Goldstein.   

Abstract

As the clinical utility of glycated hemoglobin (gHb) measurement increases, so does the need for standardization of values between different methods and different laboratories. Using three different methods, we examined the feasibility of interlaboratory standardization of gHb measurement. A liquid-chromatographic (HPLC) system from our research laboratory was designated the reference method. For gHb standards we used erythrocyte hemolysates prepared from blood samples from nondiabetic and diabetic subjects. Values assigned to each standard were based on the mean of multiple gHb determinations by the HPLC method. A clinical laboratory routinely prepared hemolysates and assayed gHb by commercially available ion-exchange ("mini column") and affinity chromatographic methods. For each assay a standard curve was constructed and gHb values were derived from these curves. Samples analyzed in the clinical laboratory were also analyzed in the research laboratory and the curve-derived values were compared with the HPLC-measured values, to determine the accuracy of our interlaboratory standardization procedure. Correlations were excellent (r = 0.99). The lack of significant differences between calculated and HPLC-measured values indicates that interlaboratory standardization is feasible.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943200

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  HbA1c standardisation destination--global IFCC Standardisation. How, why, where and when--a tortuous pathway from kit manufacturers, via inter-laboratory lyophilized and whole blood comparisons to designated national comparison schemes.

Authors:  Ian Goodall
Journal:  Clin Biochem Rev       Date:  2005-02

2.  Peripheral Arterial Disease and Its Association With Arsenic Exposure and Metabolism in the Strong Heart Study.

Authors:  Jonathan D Newman; Ana Navas-Acien; Chin-Chi Kuo; Eliseo Guallar; Barbara V Howard; Richard R Fabsitz; Richard B Devereux; Jason G Umans; Kevin A Francesconi; Walter Goessler; Lyle T Best; Maria Tellez-Plaza
Journal:  Am J Epidemiol       Date:  2016-11-03       Impact factor: 4.897

3.  Cadmium exposure and incident peripheral arterial disease.

Authors:  Maria Tellez-Plaza; Eliseo Guallar; Richard R Fabsitz; Barbara V Howard; Jason G Umans; Kevin A Francesconi; Walter Goessler; Richard B Devereux; Ana Navas-Acien
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-11

Review 4.  The long and winding road to optimal HbA1c measurement.

Authors:  Randie R Little; Curt L Rohlfing
Journal:  Clin Chim Acta       Date:  2013-01-11       Impact factor: 3.786

5.  Cadmium exposure and incident cardiovascular disease.

Authors:  Maria Tellez-Plaza; Eliseo Guallar; Barbara V Howard; Jason G Umans; Kevin A Francesconi; Walter Goessler; Ellen K Silbergeld; Richard B Devereux; Ana Navas-Acien
Journal:  Epidemiology       Date:  2013-05       Impact factor: 4.822

6.  Lectin-based estimation of glycated hemoglobin in diabetes mellitus.

Authors:  Pranab S Basu; Sudip Chatterji; Sandip K Batabyal
Journal:  J Clin Lab Anal       Date:  2012-01       Impact factor: 2.352

7.  Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident CVD: the strong heart study.

Authors:  Nawar M Shara; Helaine E Resnick; Li Lu; Jiaqiong Xu; Suma Vupputuri; Barbara V Howard; Jason G Umans
Journal:  J Nephrol       Date:  2009 May-Jun       Impact factor: 3.902

Review 8.  Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus.

Authors:  A N Goudswaard; N J Furlong; G E H M Rutten; R P Stolk; G D Valk
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

9.  Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study.

Authors:  Hong Wang; Nawar M Shara; Elisa T Lee; Richard Devereux; Darren Calhoun; Giovanni de Simone; Jason G Umans; Barbara V Howard
Journal:  Diabetes Care       Date:  2011-07-25       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.